FunPep Company Limited agreed to acquire Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others.
July 13, 2022
Share
FunPep Company Limited (TSE:4881) agreed to acquire Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others on July 14, 2022. As per the teams of the deal 6,500 shares of the FunPep Company Limited will be allotted and delivered for each Anti-Aging Peptide share. Anti-Aging Peptide Co., Ltd. reported Net worth of JPY68 million, Total assets of JPY68 million, Operating loss(EBIT) of JPY1 million and Net loss of JPY 3 million for the year ended December 31, 2021. Deal is subject to subject to approval at the extraordinary general meeting of shareholders. Share Exchange is expected to be effective on October 1, 2022.
FunPep Co Ltd is a Japan-based company engaged in the research and development business for pharmaceuticals. The main business is to promote research and development of functional peptides, which are the results of research at the Graduate School of Medicine, Osaka University, and to put them into practical use in the business fields such as pharmaceuticals, cosmetics and medical devices. The business model defines its technical area as a functional peptide-based area and a related area that has synergies with it. The Research & Development pipeline is composed of research themes for antibody-inducing peptides and developed products. The Company is engaged in the sale of peptide active ingredients through cosmetic raw material trading companies or sales companies.
FunPep Company Limited agreed to acquire Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others.